Ligand validation:6MN1

PE3: 3,6,9,12,15,18,21,24,27,30,33,36,39-TRIDECAOXAHENTETRACONTANE-1,41-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6MN1_PE3_A_307	10%	57%	0.189	0.846	0.63	1	-	1	0	0	16%	16.28
6MN1_PE3_A_306	6%	58%	0.231	0.804	0.56	1.02	-	-	0	0	23%	0.2326
6MN0_PE3_C_307	14%	51%	0.177	0.852	0.59	1.29	-	2	3	0	30%	0.3023
4Y5D_PE3_A_201	34%	36%	0.135	0.879	1.15	1.36	2	5	15	0	65%	0.6512
2VFX_PE3_C_1210	32%	71%	0.107	0.916	0.5	0.6	-	-	0	0	23%	0.2326
5DHD_PE3_A_808	30%	71%	0.095	0.916	0.43	0.67	-	-	2	0	12%	11.63
6MGJ_PE3_D_802	29%	62%	0.133	0.917	0.56	0.88	-	-	0	0	30%	0.3023
4F9Z_PE3_B_301	24%	39%	0.164	0.906	0.71	1.63	-	2	3	0	37%	0.3721

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.